👀 Ones to watch: The MOST undervalued shares to buy right nowSee Undervalued Shares

GLOBAL MARKETS-Shares jump on coronavirus drug hopes, oil surges

Published 30/04/2020, 05:09 am
© Reuters.
EUR/USD
-
US500
-
DJI
-
BA
-
MBGn
-
GILD
-
GOOGL
-
DX
-
LCO
-
CL
-
IXIC
-
VOWG_p
-
US10YT=X
-
STOXX
-
GOOG
-
MIWD00000PUS
-
SXAP
-

* MSCI global stock index up over 2%

* Gilead: remdesivir trials show improvement for COVID-19 patients

* Wall Street rises; Alphabet, Boeing (NYSE:BA) gain after results

* Oil jumps after U.S. crude inventories rise less than feared

* Fed leaves rates near zero, sees virus risks lingering

(Updates with Fed decision, afternoon trading)

By Lewis Krauskopf

NEW YORK, April 29 (Reuters) - World stock markets surged on Wednesday following encouraging news for an experimental COVID-19 treatment and some positive earnings reports, while beaten-up oil prices soared.

MSCI's gauge of stocks across the globe .MIWD00000PUS gained 2.47%. Major U.S. averages were up well over 2%, while the pan-European STOXX 600 index .STOXX rose 1.75%.

A top U.S. health official said Gilead Sciences Inc 's GILD.O antiviral drug remdesivir is likely to become the standard of care for COVID-19 after early results from a clinical trial showed it helped certain patients recover more quickly from the illness caused by the coronavirus. development of treatments for the virus has been seen by strategists as critical as they could help countries emerge from self-imposed lockdowns aimed at curbing the outbreak that have crippled economies.

Data on Wednesday showed the U.S. economy contracted in the first quarter at its sharpest pace since the Great Recession, falling at a 4.8% annualized rate. we wait for a vaccine, we are looking out for anything that will help us get back into society, and we're all hanging on this data on a day-by-day basis," said Linda Duessel, senior equity strategist at Federated Hermes in Pittsburgh.

The Federal Reserve left interest rates near zero and repeated a vow to do what it takes to shore up the U.S. economy amid an ongoing coronavirus pandemic that will not only "weigh heavily" on the near-term outlook but poses "considerable risks" for the medium term as well. more significant comment is that the FOMC is concerned about the downside risk to the economic outlook over the medium term, suggesting they will remain extraordinarily accommodative in policy for several years to come," said Guy LeBas, chief fixed income strategist at Janney Montgomery Scott in Philadelphia

Wall Street's main indexes pared gains slightly after the Fed decision, but were still sharply higher. The Dow Jones Industrial Average .DJI rose 609.64 points, or 2.53%, to 24,711.19, the S&P 500 .SPX gained 83.34 points, or 2.91%, to 2,946.73 and the Nasdaq Composite .IXIC added 315.80 points, or 3.67%, to 8,923.53.

As the heart of first-quarter corporate results season arrives, Google parent Alphabet's GOOGL.O shares jumped 9.7% after the company said a drop in Google ad sales steadied in April, with shares of other tech titans also rallying. Boeing BA.N shares rose 8.7% after the planemaker's report. Europe, shares of automakers .SXAP were lifted after German carmaker Daimler DAIGn.DE forecast operating profit at its Mercedes-Benz Cars & Vans division above the prior-year level and rival Volkswagen VOWG_p.DE said it expected to be profitable on a full-year basis. across the world are growing confident the COVID-19 pandemic may be peaking as parts of the United States, Europe and Australia gradually ease restrictions. New Zealand this week allowed some businesses to reopen.

Oil prices surged after U.S. crude stockpiles grew less than expected and gasoline posted a surprise draw, adding to optimism for an improvement in demand as some European countries and U.S. cities move to ease coronavirus lockdowns. West Texas Intermediate (WTI) crude CLc1 futures settled at $15.06 a barrel, jumping $2.72, or 22%. Brent crude futures LCOc1 settled at $22.54 a barrel, up $2.08, or 10.2%.

In currencies, the dollar index, tracking the greenback against six major peers =USD , fell 0.341%, with the euro EUR= up 0.55% to $1.0877.

Benchmark U.S. 10-year notes US10YT=RR last fell 6/32 in price to yield 0.6285%, down from 0.61% late on Tuesday.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global assets

http://tmsnrt.rs/2jvdmXl Global currencies vs. dollar

http://tmsnrt.rs/2egbfVh Emerging markets

http://tmsnrt.rs/2ihRugV MSCI All Country World Index Market Cap

http://tmsnrt.rs/2EmTD6j

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.